DM in px. by Nure
DM in px. by Nure
DM in px. by Nure
Mohammed(MRHN)
INCIDENCE
Affects2-3% of pregnancies
The most common medical complication
of pregnancy
90% are GDM
2
CLASSIFICATION
PREGESTATIONAL
TYPE 1 : IDDM
TYPE 2: NIDDM
GESTATIONAL
3
PHYSIOLOGIC CHANGE
6
GESTATIONAL DIABETES
DEFINITION
8
SCREENING
At 24-28 weeks but earlier if there is high degree of suspicion
Universal screening: All pregnant women
Selective: based on risk factors
– Age >30 yrs
– Previous infant > 4 Kg
– History of GDM
– Family history Of diabetes
– Obesity
– Polyhydramnios
– Previous unexplained perinatal loss
– << birth of a malformed child
– Glycosuria
– Polycystic ovary syndrome
– Current use of glucocorticoids
9 – Personal birth weight of over 4.5kg
SCREENING…
SCREENING PROTOCOL
– 75 gm glucose is taken po after 8-14 hours of
fasting and diagnosed if
– FBG =92–125 mg/dL (5.1–6.9 mmol/L)
– If 1hr BGL = 180 mg/dL (10.0 mmol/L)
– 2hr BGL = 153–199 mg/dL (8.5–11.0 mmol/L)
10
COMPLICATIONS
MATERNAL
– Abortion
– Pre-eclampsia
– Infection- wound, UTI ( 3-4X increased risk)
– Polyhydramnios
– APH & PPH
– DKA
– Retinopathy
– Nephropathy
– Peripheral neuropathy
– Hypo/ Hyper glycemia
– Increased risk of operative delivery
– Puerperal sepsis
11
COMPLICATIONS…
– Congenital anomaly
Cardiac( most common)
Neural tube defect
Renal & GI
12
COMPLICATIONS…
13
MGT of pregestational DM
PRECONCEPTION CARE
RX DM complication
Optimize thyroid hormones
Review current medication
Measure HbA1C
Target BGL
FBS=80-110mg/dl
2HR BGL<150mg/dl
14
Folicsuplimention/3month
Counseling
Diet
Complication
Effective contraception
regular exercise and weight control
15
Pregnancy is not recommended if
ischemic heart disease
active proliferative retinopathy (untreated)
severe renal insufficiency
creatinine clearance 2.0 mg/dL or
heavy proteinuria (>2g/24hr.)
Hgb A1c >10%.
16
ANC of pregestational DM
Screening for medical complication
Baseline investigations (RFT, urine protein
level, RFT)
Follow up
oQ 2 – 3 weeks during the first 2TP
oQ1-2 weeks until 36 weeks
o weekly until delivery.
oU/S 1st,2nd and 3rd TP
17
Preclampsia prevention
Blood Glucose Monitoring
By combination of diet, exercise, and insulin
therapy
18
Target BGL
FBS= 95 mg/dL or less
Premeal values of 100 mg/dL or less
1-hour postprandial levels of 140 mg/dL or less
2-hour postprandial values of 120 mg/dL or less.
During the night, glucose levels should not decrease to less than
60 mg/dL.
Hb A1C concentration no higher than 6%
NOTE
In resource poor settings FBS & 2hrs postprandial should be
checked at least twice weekly.
19
Dietary management
Total calories
30 Kcal/kg/day if ideal body weight
24 Kcal/ Kg /Day if 20-25% above ideal weight,
12-18 Kcal/ Kg /Day if more than 50% above ideal body weight and
36-40 Kcal/ Kg /Day if more than 10% below ideal body weight].
20
Distribution of calories
Breakfast
The breakfast meal should be small (10% of total
calories)
Carbohydrate intake at breakfast is also limited since
insulin resistance is greatest in the morning.
Lunch: 30% of total calories, dinner: 30% of total
calories, snacks:30% of total calories are distributed, as
needed
21
Exercise
o Non strenuous exercise, 3 times per week for 30 – 60 minutes.
oUsing the upper body and walking appear to be more
appropriate.
oContraindications to exercise include PIH, PROM, preterm labor,
incompetent cervix, persistent 2nd or 3rd trimester bleeding and
IUGR.
22
INSULIN TERAPY
Starting insulin dose is 0.7-1.0 units/kg daily
A combination of short & intermediate acting
insulin is necessary to maintain glucose levels
Target BGL 70-130 mg/dl
23
MANAGEMENT …
Insulin
– If FBG is > 105 mg/dl or 2hr BG is > 120 mg/dl
– Starting dose
0.6u/Kg, 0.7u/Kg & 0.8u/Kg in the 1st , 2nd & 3rd trimester
– 2/3 in the morning & 1/3 in the evening
– For the morning
2/3 intermediate acting & 1/3 short acting
– For the evening
1/2 intermediate acting & 1/2 short acting
– Oral hypoglycemic agent is not recommended
As it causes fetal & neonatal hypoglycemia
24
MANAGEMENT …
Timing of delivery
– Depending on metabolic control & fetal
condition
– 38-40 wks
– Fetal monitoring especially for insulin
requiring
Route of delivery
– C/S for macrosomia( wt > 4500g) and other
obstetric indications
25
MANAGEMENT …
Labor
– Withhold morning insulin before an elective
induction or C/S
– Intrapartum 5% or 10% glucose & regular insulin
infusion at a rate of 0.5-2u/hr
10u
regular insulin in 5%/10% DNS at a rate of 100-
125ml/hr
– Blood glucose measurement every 2 hrs
26
MANAGEMENT …
Puerperium
– Honeymoon period with decreased insulin requirement
after delivery
– GDM patients usually don’t need insulin
– For pre-gestational diabetes 2/3 of the pre-pregnancy dose
or ½ of the present dose
– Blood glucose measurement every 6 hrs
– Breast feeding is encouraged
– 75g OGTT at 6th wks for GDM- diabetes diagnosed if
FBS is > 126mg/dl or
2hrs post challenge measurement is > 200mg/dl
27
MANAGEMENT …
Contraception
– Tubal ligation if family is completed
– Barrier methods
– Low dose OCPs- in well controlled cases
– IUD
– DMPA & implant- not recommended why??
28
Management of gestational DM
Insulin indicated when
1hr postprandial values exceed 130–140 mg/dL or
2hr postprandial values exceed 120 mg/dL or
fasting glucose exceeds 92mg/dL persistently over
2weeks
Metformin can be used if insulin is not appropriate
29
Timing and route of delivery
Delivery can be planned between 39 and 40wks, but
not later than 40wks. •
Induction of labor is recommended at 38wks in
patients with poor glycemic control. • If early delivery is
indicated (before 39wks) lung maturity should be
checked •
CS is done only for obstetric indications
30
Postpartum follow up
RBS 4 hours of delivery
If FBG exceed 126 mg/dL or RBS exceeds
200mg/dL, insulin in a lower dose (usually one third to
half of the antenatal dose) or metformin would be
required •
If the mother received insulin in the antenatal period,
the dose needs adjustments to pre pregnant doses in
those with type 2 diabetes mellitus
31
For those with GDM, no treatment is required and
usually maintained on diet alone.
Note that determination of OGTT at 6 - 12 wks
postpartum is required to exclude overt diabetes.
Ensure that women who have preproliferative
diabetic retinopathy or
any form of referable retinopathy diagnosed during
pregnancy have ophthalmological follow-up for at
least 6 months
32
FAMILY PLANNING
All reliable method of family planning can be used
Combined hormonal contraceptives and DMPA
should be avoided in women with pregestational DM
who have vascular complications
Permanent methods of contraception are ideal if
family size is complete
33
KETO ACIDOSIS DURING
PREGNANCY
Definition
– Plasma glucose >300mg/dl, HCO3<15mEq/l &
PH<7.3
Risk factors
– Infection, volume depletion, failure to take insulin & C/S
Management
– Lab assessment
– Insulin – regular insulin 10-20 u IV then 5-10 u/hr
– IV fluid( 4- 6L in the 1st 12 hrs)
– Potassium
– bicarbonate
34